Company: PTPI
Filing Date: 2025-02-14
Form Type: S-1/A
Source: 0001410578-25-000137
Chunk: 0

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-14
Form: S-1/A
Chunk 0
---
As filed with the Securities and Exchange Commission on February 14, 2025 Registration No. 333-284495 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Petros Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter)

| Delaware                        |                                        2834 | 85-1410058            |
| (State or other jurisdiction of 
 incorporation or organization)  | -primary standard industrial classification 
                                 code number | -I.R.S. Employer      
 Identification Number |

1185 Avenue of the Americas, 3 rd Floor New York, New York 10036 (973) 242-0005 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Fady Boctor President and Chief Commercial Officer Petros Pharmaceuticals, Inc. 1185 Avenue of the Americas, 3 rd Floor New York, New York 10036 (973) 242-0005 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to:

| Rick A. Werner, Esq.Alla Digilova, Esq.Haynes and Boone, LLP30 Rockefeller Plaza, 26th FloorNew York, NY 10112212-659-7300 | M. Ali Panjwani, Esq.David E. Fisher, Esq.  Pryor Cashman LLP7 Times SquareNew York, New York 10036(212) 421-4100 |

Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed